Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 19942562)

1.

Pulmonary arterial hypertension: many years' experience and modern approach to a malignant disease in a pulmonary hypertension centre.

Karyofillis P, Manginas A, Thomopoulou S, Balanos D, Spargias K, Cokkinos DV.

Hellenic J Cardiol. 2009 Nov-Dec;50(6):484-92.

2.

The prognosis in children with pulmonary arterial hypertension: 10 years single centre experience.

Żuk M, Mazurkiewicz-Antoń K, Migdał A, Jagiełłowicz-Kowalska D, Turska-Kmieć A, Ziółkowska L, Brzezińska-Rajszys G, Zubrzycka M, Kawalec W.

Kardiol Pol. 2015 Jun 23. doi: 10.5603/KP.a2015.0120. [Epub ahead of print]

3.

Acute vasoreactivity test results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease: our experience with 29 cases.

Asker S, Asker M.

Int J Chron Obstruct Pulmon Dis. 2015 May 28;10:969-73. doi: 10.2147/COPD.S82856. eCollection 2015.

4.

Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis.

Bandyopadhyay D, Bajaj NS, Zein J, Minai OA, Dweik RA.

Eur Respir J. 2015 May 28. pii: ERJ-02155-2014. doi: 10.1183/09031936.00215514. [Epub ahead of print]

PMID:
26022959
5.

Measuring vasoreactivity in pulmonary hypertension: a simple test, but do we understand it?

Lang IM.

J Heart Lung Transplant. 2015 Mar;34(3):306-7. doi: 10.1016/j.healun.2014.12.002. Epub 2014 Dec 19. No abstract available.

PMID:
25813763
6.

Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.

del Cerro Marín MJ, Sabaté Rotés A, Rodriguez Ogando A, Mendoza Soto A, Quero Jiménez M, Gavilán Camacho JL, Raposo Sonnenfeld I, Moya Bonora A, Albert Brotons DC, Moreno Galdó A; REHIPED Investigators.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1421-9. doi: 10.1164/rccm.201406-1052OC.

PMID:
25379685
7.

Functional class and targeted therapy are related to the survival in patients with pulmonary arterial hypertension.

Park YM, Chung WJ, Choi DY, Baek HJ, Jung SH, Choi IS, Shin EK.

Yonsei Med J. 2014 Nov;55(6):1526-32. doi: 10.3349/ymj.2014.55.6.1526.

8.

Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience.

Idrees M, Al-Najashi K, Khan A, Al-Dammas S, Al-Awwad H, Batubara E, Al Otai A, Abdulhameed J, Fayed A, Kashour T; SAPH Registry Taskforce.

Ann Thorac Med. 2014 Oct;9(4):209-15. doi: 10.4103/1817-1737.140127.

9.

[Analysis of factors related to pulmonary hypertensive crisis in patients with idiopathic pulmonary arterial hypertension].

Zhang C, Li Q, Zhu Y, Gu H.

Zhonghua Yi Xue Za Zhi. 2014 Jun 10;94(22):1687-91. Chinese.

PMID:
25151895
10.

Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.

Keir GJ, Walsh SL, Gatzoulis MA, Marino PS, Dimopoulos K, Alonso R, Raposeiras-Roubin S, Renzoni EA, Maher TM, Wells AU, Wort SJ.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):82-90.

PMID:
25078636
11.
12.

[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].

Kaemmerer H, Gorenflo M, Hoeper M, Huscher D, Ewert P, Pittrow D.

Dtsch Med Wochenschr. 2013 Jun;138(23):1247-52. doi: 10.1055/s-0033-1343189. Epub 2013 May 29. Review. German.

PMID:
23720182
13.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Chen J, Gao Y, Deng B, Liu K.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD004434. doi: 10.1002/14651858.CD004434.pub5. Review.

PMID:
23450552
14.

Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

McCabe C, Bennett M, Doughty N, MacKenzie Ross R, Sharples L, Pepke-Zaba J.

Chest. 2013 Aug;144(2):522-30. doi: 10.1378/chest.12-2443.

PMID:
23430021
15.

[Relationship between serum uric acid levels and patient conditions and prognosis in idiopathic pulmonary arterial hypertension].

Li ZN, He JG, Liu ZH, Gu Q, Ni XH, Cheng XS, Xiong CM.

Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3261-4. Chinese.

PMID:
23328510
16.

Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data.

Dobarro D, Schreiber BE, Handler C, Beynon H, Denton CP, Coghlan JG.

Am J Cardiol. 2013 Jan 15;111(2):278-85. doi: 10.1016/j.amjcard.2012.09.031. Review.

PMID:
23290599
17.

Building a pulmonary vascular service: the 12-year experience and outcomes of the Auckland pulmonary arterial hypertension clinic.

Wasywich CA, Cicovic A, McWilliams T, Coverdale HA, Stewart C, Whyte K.

Intern Med J. 2013 Jun;43(6):635-42. doi: 10.1111/imj.12069.

PMID:
23279376
18.

[Clinical analysis of 150 patients with idiopathic pulmonary arterial hypertension].

Dong L, He JG, Shan GL, Lu XL, Zeng WJ, Liu ZH, Zhou DX, Cao H, Ni XH, Wang GY, Shen JY, Tian HY, Sun YJ, Gu Q, Zhao ZH, Cheng XS, Xiong CM.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Aug;40(8):657-61. Chinese.

PMID:
23141009
19.

[Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension].

Jia WB, Jiang X, Zuo XR, He J, Zhao QH, Jiang R, Jing ZC.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Aug;40(8):652-6. Chinese.

PMID:
23141008
20.

HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance?

Belly MJ, Tiede H, Morty RE, Schulz R, Voswinckel R, Tanislav C, Olschewski H, Ghofrani HA, Seeger W, Reichenberger F.

J Heart Lung Transplant. 2012 Oct;31(10):1109-14. doi: 10.1016/j.healun.2012.08.014.

PMID:
22975101
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk